[EllaC]

Ashwagandha inhibits the growth of human breast, lung, and colon cancer cells comparably to the chemo drug doxorubicin (in lab studies). Withaferin A, a compound in ashwagandha, was more effective than doxorubicin in stopping breast and colon cancer cell growth.
• Ashwagandha disrupts the ability of cancer cells to reproduce, which is a key to fighting cancer.
• Lab analysis shows that ashwagandha has the ability to prevent cancer from forming the new blood vessels it needs to support its uncontrolled growth. Stopping this process (called angiogenesis) is likewise a key to fighting cancer.
• In animal trials, ashwaghanda also inhibited induced stomach cancer. Overall tumor incidence dropped by 60% and the number of tumors (multiplicity) plummeted by 92%. The results were similar when tested with rodents and skin cancer, reducing tumor incidence by 45% and multiplicity by 71%.
•Other studies have also confirmed ashwagandha's protective benefit against skin cancer.
• Another experiment showed it increased life span and decreased tumor weight in experimental animals with induced lymphatic cancer.

These are exciting findings suggesting ashwagandha could give patients a huge boost in battling cancer.